Kathryn R. Judson
Associate
Kathryn Judson focuses on complex patent litigation involving pharmaceuticals, chemicals, and biotechnology. Her practice includes Hatch-Waxman litigation related to Abbreviated New Drug Applications (ANDA) and post-grant proceedings before the U.S. Patent and Trademark Office (USPTO). Kathryn also has experience with renewable energy technologies.
Experience
Vifor (International) AG and American Regent, Inc. v. Mylan Labs. Ltd. et al.
Represented Vifor and American Regent in two Hatch-Waxman Act cases against Mylan and Sandoz regarding their attempts to obtain FDA approval for their respective ANDAs directed to generic copies of Injectafer®. After a six-day bench trial, the cases resulted in a favorable settlement for our clients with a generic entry date well past the expiration of the composition patents.
3:19-cv-13955, 3:19-cv-16305, D.N.J., Judges Wolfson, Arpert
Successfully represented Bausch & Lomb and Eye Therapies in a Hatch-Waxman patent infringement litigation and parallel PTAB challenges concerning an ANDA for generic versions of over-the-counter Lumify® ocular drops. The cases settled favorably for our clients.
3:21-cv-16766, D.N.J., Judges Kirsch, Singh
IPR2022-00146, PTAB, Judges Hulse, New, Pollock
IPR2024-00467, PTAB, Judges Flax, Pollock, Yang
IPR2022-00142, PTAB, Judges Flax, Hulse, New, Pollock
Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof
Representing respondent Wacker Biotech GmbH in a rare section 337 ITC investigation involving drug products containing C-type natriuretic peptide variants.
337-TA-1447, ITC, Judge Cheney
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Trial counsel for Novartis in district court litigation against multiple generics related to KISQALI ®, a blockbuster, breakthrough CDK4/6-inhibitor for the treatment of breast cancer. After a bench trial, the case resulted in a favorable settlement for our client, supporting patent protection at least until 2031.
1:21-cv-00870, D. Del., Judge Hall
Kaken Pharmaceutical Co., Ltd.; Bausch Health Care v. Zydus Pharmaceuticals (USA) Inc. et al.
Successfully led Kaken and Bausch Health Care in inter partes review (IPR) proceedings, district court litigation, and Federal Circuit appeal related to patent covering Kaken and Bausch Health Care’s Jublia® (efinaconazole) product for the treatment of onychomycosis.
3:18-cv-13635, D.N.J., Judges Martinotti, Goodman
18-2232, Fed. Cir., Judges Newman, O'Malley, Taranto
IPR2017-00190, PTAB, Judges Mitchell, Franklin, Pollock
IPR2017-01429, PTAB, Judges Mitchell, Franklin, Pollock
American Regent, Inc. v. Pharmacosmos Therapeutics Inc. et al.
Successfully represented American Regent in litigation in the District of New Jersey against Pharmacosmos and their branded drug, Monoferric®, related to American Regent patents covering the use of iron carbohydrate complexes for the treatment of iron deficiency diseases. The case resulted in a favorable settlement for our client. This representation follows successful representation of American Regent in related post-grant review proceeding.
PGR2020-00009, PTAB, Judges Tornquist, Franklin, Wisz
3:20-cv-01350, D.N.J., Judges Goodman, Martinotti, Quraishi
News
Professional Activities
- Intellectual Property Law Society
(President, 2018-2019; Treasurer, 2017-2018) - American Intellectual Property Law Association
- ChIPs: Advancing Women in IP
Admissions
- Georgia
- U.S. Court of Appeals, Federal Circuit
- U.S. Court of Appeals, Sixth Circuit
- U.S. Court of Appeals, Veterans Claims
Education
- Florida State University College of Law
- J.D., 2019
- Florida State University College of Law
- Certificate, Business Law Concentration, cum laude, 2019
- University of South Florida
- B.S., Environmental Science and Policy, magna cum laude, 2016
Kathryn's Practices
- Global IP Enforcement, Litigation, and Trials
- Branded Hatch-Waxman (ANDA) Litigation and Trials
- Design Rights
- Patent Litigation and Trials
- Trademark Litigation and Trials
- Patent Office Invalidation Proceedings
- PTAB Invalidation Proceedings: IPR and PGR
- Prosecution and Portfolio Management
- Design Rights
- Patent Drafting and Prosecution
- Trademark Counseling and Prosecution
- Trademark and Brand Management
- Design Rights
- Trademark Counseling and Prosecution
Kathryn's Industries
- AI, Electronics, and Information Technology
- Augmented Reality/Virtual Reality (AR/VR)
- Chemicals, Industrials, and Materials
- Chemical
- Textiles
- Consumer Goods and Services
- Food and Beverage
- Energy
- Clean Energy and Renewables
- Oil and Gas
- Life Sciences
- Biologics
- Biotechnology
- Digital Health
- Medical Device and Diagnostics
- Pharmaceutical
- Transportation and Logistics
- Automotive and Smart Mobility Tech